多模式分析揭示了区分EBV阳性和EBV阴性移植后淋巴增殖疾病的瘤和免疫特征

Jiaying Toh1, Andrea J Reitsma2, Tetsuya Tajima2

  • 1Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA; PhD Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA; Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA, USA.

Cell reports. Medicine
|December 10, 2024
PubMed
概括

爱斯坦-巴尔病毒 (EBV) 在移植后淋巴增殖性疾病 (PTLD) 中产生明显的差异. 与EBV(+) PTLD不同,EBV(+) PTLD B细胞调节瘤微环境,提供新的治疗点.